Medivir AB (MVIR B):企業財務及び戦略的SWOT分析

◆英語タイトル:Medivir AB (MVIR B) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single UserUSD300 ⇒換算¥33,600見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,200見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥100,800見積依頼/購入/質問フォーム


Medivir AB (Medivir) is a biopharmaceutical company that conducts research and develops new drugs for the treatment of infectious diseases. The company concentrates on research and development in infectious diseases, osteoarthritis, neuropathic pain and oncology. It offers respiratory system products, cardiovascular system products, stomach and intestine products, musculoskeletal system products, pain management products, zinc supplements, and CNS products. Medivir also provides drugs for the disorders such as hepatitis C, mouth ulcers, zinc deficiency, psychiatry, HIV, bone disorders, and neuropathic pain. The company’s products are in discovery and preclinical development stages. It operates through research unit in Huddinge, Sweden. Medvir is headquartered in Stockholm, Sweden.

Medivir AB Key Recent Developments

Nov 10, 2016: Medivir: Interim Report, January – September 2016
Oct 10, 2016: Medivir Focuses Exclusively on Oncology and Reorganizes to Significantly Reduce the Cost Structure
Aug 31, 2016: Medivir Proceeds with a Separation of the Company’s Operations
Aug 17, 2016: Medivir – Interim Report, January – June 2016
Jun 15, 2016: Medivir Investigates Possible Corporate Split and Separate Listing of Commercial Operations

This comprehensive SWOT profile of Medivir AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Medivir AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Medivir AB – Key Information
Medivir AB – Overview
Medivir AB – Key Employees
Medivir AB – Key Employee Biographies
Medivir AB – Key Operational Heads
Medivir AB – Major Products and Services
Medivir AB – History
Medivir AB – Company Statement
Medivir AB – Locations And Subsidiaries
Medivir AB – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Medivir AB – Business Description
Medivir AB – Corporate Strategy
Medivir AB – SWOT Analysis
SWOT Analysis – Overview
Medivir AB – Strengths
Medivir AB – Weaknesses
Medivir AB – Opportunities
Medivir AB – Threats
Medivir AB – Key Competitors

Section 3 – Company Financial Performance Charts

Medivir AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Medivir AB, Key Information
Medivir AB, Key Ratios
Medivir AB, Share Data
Medivir AB, Major Products and Services
Medivir AB, History
Medivir AB, Key Employees
Medivir AB, Key Employee Biographies
Medivir AB, Key Operational Heads
Medivir AB, Other Locations
Medivir AB, Subsidiaries
Medivir AB, Key Manufacturing facilities
Medivir AB, Key Competitors
Medivir AB, SWOT Analysis
Medivir AB, Ratios based on current share price
Medivir AB, Annual Ratios
Medivir AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Medivir AB, Performance Chart
Medivir AB, Ratio Charts


★リサーチレポート[ Medivir AB (MVIR B):企業財務及び戦略的SWOT分析(Medivir AB (MVIR B) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。